Načítá se...
Isocitrate dehydrogenase 1 mutation subtypes at site 132 and their translational potential in glioma
In recent years, de novo missense structural mutations in the IDH1 gene of arginine at site 132 (R132) have become a standard for diagnostication and prognostication in glioma management. As our clinical understanding of this mutation grows, so too does the number of mutation subtypes reported in th...
Uloženo v:
| Vydáno v: | CNS Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Medicine Ltd
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6001689/ https://ncbi.nlm.nih.gov/pubmed/29303363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns-2017-0019 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|